Cutera, Inc. to Participate in Upcoming Investor Conferences
November 10, 2023 at 05:08 pm EST
Share
Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, today announced that Taylor Harris, Chief Executive Office, and Greg Barker, Vice President of Corporate FP&A and Investor Relations, will participate in Fireside Chats at the following upcoming investor conferences:
Stifel 2023 Healthcare Conference, 2:25pm ET on Wednesday, November 15, 2023, at the Lotte New York Palace Hotel, New York, NY
Stephens Annual Investment Conference, 9:00am CT on Thursday, November 16, 2023, at the Grand Hyatt Hotel, Nashville, TN
Piper Sandler Annual Healthcare Conference, 3:00pm ET on Wednesday, November 29, 2023, at the Lotte New York Palace Hotel, New York, NY
The fireside chats will also be webcast and can be accessed from the Investor Relations section of Cutera’s website at http://www.cutera.com/. The webcast replay will be available at the same site approximately one hour after the end of the event.
About Cutera, Inc.
Cutera is a leading provider of aesthetic and dermatology solutions for practitioners worldwide. Since 1998, Cutera has been developing innovative, easy-to-use products that harness the power of science and nature to enable medical practitioners to offer safe and effective treatments to their patients. For more information, call +1-415-657-5500 or 1-888-4CUTERA or visit www.cutera.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231110029549/en/
Cutera, Inc. develops, manufactures, distributes, and markets energy-based product platforms for medical practitioners, enabling them to offer treatments to their customers. The Company distributes third-party manufactured skincare products and secret systems and consumables. Its system platforms include AviClear, enlighten, excel, truSculpt, Secret PRO, Secret RF, and xeo. The Companyâs Cutera Core segment consists of the Companyâs systems, consumables, skincare, and service businesses. The Cutera Core segment develops, distributes and manufactures energy-based systems for medical practitioners in addition to distributing third-party manufactured skincare products in Japan. The Companyâs AviClear segment consists of the AviClear business. The Companyâs acne solution, AviClear, is a prescription-free, drug-free laser treatment for the treatment of mild to severe acne. Its products include CUTERA, ACUTIP 500, AVITM, AVI360, AVIANALYTICSTM, AVICARE COOLGLIDE, and more.